Suppr超能文献

在SHR-SP模型中,西氯他宁与其他抗高血压药物的比较。

Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.

作者信息

Malherbe E, Le Hegarat M, Clostre F, Braquet P

机构信息

Henri Beaufour Institute, Le Plessis-Robinson, France.

出版信息

Drugs Exp Clin Res. 1988;14(2-3):83-8.

PMID:2970955
Abstract

The effects of cicletanine were compared with those of four other antihypertensive drugs (prazosin, a highly selective alpha 1 antagonist; captopril, an angiotensin-converting enzyme inhibitor; indapamide, an antihypertensive diuretic; and hydrochlorothiazide, a purely diuretic agent) on young stroke-prone SHR rats with high-salt diet. All the drugs except hydrochlorothiazide prevented the onset of hypertension. The minimal effective dose on blood pressure was 1 mg/kg for both cicletanine and captopril, and 3 mg/kg for indapamide. The action on cardiac hypertrophy and diuresis occurs at a dose of cicletanine 10 to 30 times higher than that required to produce the antihypertensive effect. Renal hypertrophy was also decreased significantly by cicletanine at a dose of 100 mg/kg.

摘要

在高盐饮食的年轻易中风自发性高血压大鼠(SHR)中,将西氯他宁的作用与其他四种抗高血压药物(哌唑嗪,一种高选择性α1拮抗剂;卡托普利,一种血管紧张素转换酶抑制剂;吲达帕胺,一种抗高血压利尿剂;氢氯噻嗪,一种单纯的利尿剂)进行了比较。除氢氯噻嗪外,所有药物均能预防高血压的发生。西氯他宁和卡托普利对血压的最小有效剂量均为1mg/kg,吲达帕胺为3mg/kg。西氯他宁产生抗高血压作用的剂量比其产生心脏肥大和利尿作用的剂量低10至30倍。西氯他宁100mg/kg的剂量也能显著降低肾脏肥大。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验